Breonics, Inc.
Records under this name other than patents Breonics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,994,811 | Reducing the immunogenicity of allografts Lapsed on the fee record Ended Jun 12, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2026 | From the USPTO record |
| US 8,748,164 | Delivery system for cell-based therapies Lapsed on the fee record Ended Jun 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | From the USPTO record |
| US 9,232,784 | Methods and compositions to modify the immunogenicity of a vascularized organ or tissue Lapsed on the fee record Ended Jan 12, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 12, 2024 | From the USPTO record |
| US 7,985,536 | Method for regulating NO production in an isolated organ or tissue during warm perfusion Term ended Term ended Sep 25, 2022 · From the USPTO record | Term ended | Term ended Sep 25, 2022 | From the USPTO record |
| US 6,747,132 | Methods for the synthesis of a modified hemoglobin solution Term ended Term ended Sep 24, 2021 · From the USPTO record | Term ended | Term ended Sep 24, 2021 | From the USPTO record |
| US 6,582,953 | Organ chamber for exsanguinous metabolic support system Term ended Term ended Apr 12, 2020 · From the USPTO record | Term ended | Term ended Apr 12, 2020 | From the USPTO record |
| US 6,642,045 | System for exsanguinous metabolic support of an organ or tissue Term ended Term ended Apr 12, 2020 · From the USPTO record | Term ended | Term ended Apr 12, 2020 | From the USPTO record |
| US 7,038,016 | Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution Lapsed on the fee record Ended May 2, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2018 | From the USPTO record |
| US 6,024,698 | Apparatus for monitoring functional characteristics of an organ intended for transplantations Term ended Term ended Dec 17, 2017 · From the USPTO record | Term ended | Term ended Dec 17, 2017 | From the USPTO record |
| US 6,375,613 | Prognostic testing of organs intended for transplantation Lapsed on the fee record Ended Apr 23, 2014 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2014 | From the USPTO record |